Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male, Female and Transgenders. ï?· Age between 18 to 85 years ï?· COVID 19 positive asymptomatic / pre symptomatic, mild and moderately and severely symptomatic patients. ï?· Willing to consent to the study.
Exclusion criteria
Exclusion criteria: High risk groups (Patients with Complications of Diabetes, Heart diseases, Cancer and Pregnancy) ï?· Multi organ failure Syndrome (MODS). ï?· Patients participating in other COVID 19 trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome would be measured through Reduction of symptoms and Recovery of patients from COVID 19 disease in a time bound manner.Conversion of RT PCR negative within first week of accelerated recoveryTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible reduction of viral load data in subjects both at baseline and at 7 days, and 14 days or at recovery or 30 days whichever is earlier.. ï?· Number of days on treatment before recovery and Case fatality rate will also be noted. ï?· Reduction in Signs and symptoms like Fever, cough, breathlessness, and improvement in O2 saturation (SpO2) and PaO2/FiO2 becoming 300mg/Hg in patients with severe grade and ARDS.Timepoint: 6 MONTHS | — |
Countries
India
Contacts
National Institute of Siddha